Cargando…
Blood-based lipidomic signature of severe obstructive sleep apnoea in Alzheimer’s disease
BACKGROUND: Obstructive sleep apnoea (OSA) is the most frequent form of sleep-disordered breathing in patients with Alzheimer’s disease (AD). Available evidence demonstrates that both conditions are independently associated with alterations in lipid metabolism. However, it is unknown whether the exp...
Autores principales: | Dakterzada, Farida, Benítez, Iván D., Targa, Adriano, Carnes, Anna, Pujol, Montse, Jové, Mariona, Mínguez, Olga, Vaca, Rafi, Sánchez-de-la-Torre, Manuel, Barbé, Ferran, Pamplona, Reinald, Piñol-Ripoll, Gerard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9632042/ https://www.ncbi.nlm.nih.gov/pubmed/36329512 http://dx.doi.org/10.1186/s13195-022-01102-8 |
Ejemplares similares
-
Cerebrospinal fluid lipidomic fingerprint of obstructive sleep apnoea in Alzheimer’s disease
por: Dakterzada, Farida, et al.
Publicado: (2023) -
Changes in Plasma Neutral and Ether-Linked Lipids Are Associated with The Pathology and Progression of Alzheimer’s Disease
por: Dakterzada, Farida, et al.
Publicado: (2023) -
Breathing cessation events that compose the apnea–hypopnea index are distinctively associated with the adverse outcomes in Alzheimer’s disease
por: Targa, Adriano D. S., et al.
Publicado: (2023) -
Plasma and cerebrospinal fluid nonenzymatic protein damage is sustained in Alzheimer's disease
por: Dakterzada, Farida, et al.
Publicado: (2023) -
The circadian rest-activity pattern predicts cognitive decline among mild-moderate Alzheimer’s disease patients
por: Targa, Adriano D. S., et al.
Publicado: (2021)